What determines the pace of embryonic development? Although many molecular mechanisms controlling 12 developmental processes are evolutionarily conserved, the speed at which these operate can vary substantially 13 between species. For example, the same genetic programme, comprising sequential changes in transcriptional 14 states, governs the differentiation of motor neurons in mouse and human, but the tempo at which it operates differs 15 between species. Using in vitro directed differentiation of embryonic stem cells to motor neurons, we show that the 16 programme runs twice as fast in mouse as in human. We provide evidence that this is neither due to differences in 17 signalling, nor the genomic sequence of genes or their regulatory elements. Instead, we find an approximately two-18 fold increase in protein stability and cell cycle duration in human cells compared to mouse. This can account for the 19 slower pace of human development, indicating that global differences in key kinetic parameters play a major role in 20 interspecies differences in developmental tempo.
INTRODUCTION

23
The events of embryonic development take place in a stereotypic sequence and at a characteristic tempo (1, 2). 4 region and/or cis-regulatory elements might determine the tempo of development. To study sequence differences 142 between species, we focused our attention on Olig2; it is the major regulator of pMN and regulatory elements for 143
Olig2 have been characterized (34, 35) . We reasoned that if sequence differences were responsible for the different 144 temporal dynamics in mouse and human cells, we would be able to detect species-specific changes in the timing of 145 Olig2 expression if we introduced the human Olig2 locus into mouse cells. The human Olig2 gene is located on 146 chromosome 21 and we took advantage of the 47-1 mouse ESC line that contains the Hsa21q arm of human 147 chromosome 21 (36). We differentiated 47-1 (hereafter referred to as hChr21) alongside its parental line, which 148 lacked Hsa21q, from which it was generated (hereafter referred to as wt). The proportions of neural progenitors and 149 the dynamics of gene expression, measured by RNA expression, immunofluorescence and flow cytometry, were 150 similar between hChr21 and wt lines (Fig. 4A,B,S3A,B) . We then assessed the timing of expression of the hOLIG2 151 allele. We detected induction of hOLIG2 at day 1 of differentiation ( Fig. 4C) , 24h after addition of RA SAG. By contrast 152 in human cells, hOLIG2 induction is not induced until day 2-3 ( Fig. 2G ). Thus, in mouse cells, hOLIG2 follows the same 153 dynamics of gene expression as mouse Olig2 (mOlig2), indicating that the temporal control of gene expression 154 depends on the cellular environment and not the species origin of the genomic sequence.
155
To compare Olig2 expression levels between the mouse and human alleles, we performed single-molecule 156 Fluorescent In Situ Hybridization (smFISH) (Fig. 4D, S3C ). We first assayed transcripts of Sox2 (mSox2), a transcription nascent proteins replacing methionine in the medium with the methionine analog L-azidohomoalanine (AHA), and 191 used FACS to measure the stability of newly synthesized proteins upon removal of the amino acid analog over the 192 course of 48h ( Fig S4C,D) . We found that the half-life of the proteome in mouse neural progenitors was shorter than 193 in human progenitors (t1/2 = 8 ± 1.6 h in mouse versus t1/2=20.5 ± 5.2h in human day 4 or t1/2=18.5 ± 2.4 in human 194 day 8), an approximate 2.5 fold difference (Fig. 5C,D) . This identifies a global difference in the protein lifetime 195 between mouse and human that corresponds to the difference in tempo.
196
To test whether changes in protein stability could account for differences in developmental tempo, we took 197
advantage of a mathematical model of the GRN, which we had previously developed (38) (Fig. 5E ). Doubling the 198 stability of the TFs to mimic human kinetics, resulted in a slower dynamic of the network with the same sequence of 199 gene expression, comparable to that observed experimentally (Fig. 5F ). To explore further the connection between 200 changes in protein stability and GRN dynamics we measured the change in time of the onset of Olig2 as a function 201 of degradation rate. This revealed a superlinear relationship in which an increase in protein stability slows GRN 202 dynamics by slightly more than the fold increase in degradation rate (Fig. 5G, S4F ). This confirms that an increase in 203 protein stability can explain the tempo changes in MN differentiation between mouse and human. In addition, the 204 analysis revealed that large changes in protein stability can lead to different sequences of gene expression, predicting 205 limits to the allochronies compatible with the GRN (Fig. S4F ).
206
A prediction that arises from this analysis is that the TFs comprising the GRN that regulate MN differentiation should 207 be more stable in human than mouse neural progenitors, and that a fold increase of protein stability close to 2 would 208 give a scaling factor of ~2.5. To this end, we performed pulse-chase experiments labeling nascent proteins with AHA, 209 conjugated labelled proteins to biotin and then streptavidin agarose beads to purify them This revealed that pan-210 neural proteins SOX1 and SOX2 had longer lifetimes than OLIG2 and NKX6.1 proteins in both species (Fig. 6A,S4G ,H).
211
Moreover, human NKX6.1 and OLIG2 were ~2 fold more stable than their mouse homologues (mNKX6.1 ≈2.5 vs. 212 hNKX6.1≈6h; mOLIG2 ≈3.5h, hOLIG2 ≈ 6.8h) ( Fig. 6A,S4G ,H). These results are consistent with the predictions made 213 by the model, revealing a non-linear relationship between degradation rates and tempo scaling.
214
The identification of a global increase in the lifetime of proteins in human compared to mouse neural progenitors 215 raised the possibility that exogenous proteins would show species-specific stability. To this end, we generated 216 Patched1-mKate2 reporter lines in mouse and human stem cells. In these lines, we fused the monomeric far-red 217 fluorescent protein Katushka-2 (mKate2) to the C-terminus of endogenous Ptch1 via a self-cleaving peptide (Fig. 
218
S5A). This way, we could modulate mKATE2 expression, driven by the Shh responsive Ptch1, using small molecule 219 activators and inhibitors of Sonic Hedgehog signalling. To measure mKATE2 lifetimes, we induced mKate2 expression 220 by addition of SAG ( Fig. S5B ). Next, we added the Smoothened antagonist Vismodegib (39) to block Shh signalling 221 and thereby repress new mKATE2 production. We then assayed the decay of mKATE2 fluorescence in inhibited cells.
222
FACS analysis showed a half-life of 17.8 ± 2.3 h for mKate2 in mouse cells. By contrast, the half-life of the same 223 mKATE2 exogenous protein in human cells was 35.09h ± 7.3 h ( Fig 6B,C) . These results indicate that protein half-life 224 is species specific.
225
The long half-life of mKATE2 raised the possibility that dilution, following cell division, contributed to the measured 226 decay rate (40). Differences in the cell cycle time between mouse and human neural progenitors could therefore 227 contribute to the difference in mKATE2 lifetime. To test this, we assayed total cell cycle length using cumulative EdU 228 labelling of mouse and human neural progenitors ( Fig. 6D ,E, S5C,D) (41). Cell cycle duration in equivalent staged 229 neural progenitors from mouse and human was 10.8h ± 8.3h compared to 28.4h ± 13.9h, respectively. Thus, similar 230 to the proteome, the cell cycle operates twice as fast in mouse compared to human. Since progress through the cell 231 cycle is controlled by protein degradation (42, 43) , the difference in cell cycle rate between mouse and human cells 232 may also be a consequence of a global change in protein stability.
233
Taken together, these data indicate that the dynamics of the gene regulatory network associated with the embryonic 234 generation of MNs progresses 2-3 times faster in mouse than in human cells. A similar difference in the tempo of 235 the segmentation clock between mouse and human has also been observed (9, 11). These differences do not appear 236 to arise from a bottleneck caused by a specific rate limiting event in MN generation. Moreover, neither changes in 237 the dynamics of signalling nor variations in genomic regulatory sequences appear to account for the species-specific 6 the temporal scaling in developmental processes results from global differences in key kinetic parameters that 240 broadly affect the tempo of molecular processes. What sets this global tempo remains to be determined but could 241 involve the differences in the rates of pivotal molecular processes such as global changes in proteostasis or 242 differences in the overall metabolic rate of cells. How these affect the pace at which GRNs elaborate and how such 243 variations are assimilated to ensure the development of robust and appropriately proportioned tissues will need to 244 be addressed, but the availability of in vitro systems that mimic in Stem Cells. 25, 1931 -1939 (2007 
537
The 47-1 (hChr21) cell line (36) was maintained with 0.8ul/mL of G418 (GIBCO) to select for cells carrying the human 538 chromosome 21.
539
H9 ESC line (WiCell), and Ptch1::T2A-mKate2 H9 ESC lines were routinely cultured in Essential 8™ medium on 540 0.5ug/cm2 laminin-coated plates (Thermo Fisher A29249), and split using Versene (Gibco 15040066).
541
To obtain mouse neural progenitors of posterior identity, mouse ESCs were dissociated with 0.05% trypsin, feeders 542 removed by differential binding to gelatin-coated plates, and 60,000-80,000 cells were plated per 35mm CELLBIND 543 dish in N2B27 medium supplemented with 10ng/ml of bFGF (100-18B Peprotech) from days -3 to -1. On day -1, 544 N2B27 was supplemented with 10ng/ml bFGF (100-18B Peprotech), 5µM CHIR99021 (Axon), 10uM SB431542 (LT 545 S0400) and 2uM DMH1 (A12820 Adooq Bioscience). From day 0 onwards cells and cultured in N2B27 supplemented To measure mKATE2 stability, cells were exposed to 100nM RA and 1uM of SAG from day 0 on the neural 724 differentiation protocol to induce maximum levels of Ptch1::T2A-mKate2 expression driven from the Ptch1 locus. 
